Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Manuel Delgado-Amaya"'
Publikováno v:
Journal of Translational Internal Medicine. 2:11-17
Hemodynamically unstable patients under continuous renal replacement therapies (CRRT) frequently show an improvement in hemodynamic parameters and a reduction in vasopressor agents. Different mechanisms have been proposed to explain this effect. A hi
Autor:
Rocio M. Aragones Manzanares, José Luis Castillo Castro, Dolores M. Arias Garcia, Miguel A. Prieto Palomino, Manuel Delgado Amaya, Juan A. Bullones Ramirez
Publikováno v:
Revista Española de Cardiología (English Edition). 57:885-888
Antagonists of the glycoprotein IIb/IIIa receptor block the binding of fibrinogen and von Willebrand factor to the platelet receptor. This effect can lead to bleeding and thrombocytopenia. We analyzed the incidence and clinical repercussions of sever
Autor:
Miguel A. Prieto Palomino, Rocio M. Aragones Manzanares, Juan A. Bullones Ramirez, Dolores M. Arias Garcia, Manuel Delgado Amaya, José Luis Castillo Castro
Publikováno v:
Revista Española de Cardiología. 57:885-888
Los antiagregantes antiglucoproteina IIb/IIIa bloquean la union del fibrinogeno y el factor de Von Willebrand a sus receptores. Pueden causar hemorragia y trombocitopenia. Se ha analizado la incidencia y la repercusion clinica de la trombocitopenia e
Autor:
Rocío M, Aragonés Manzanares, Manuel, Delgado Amaya, Juan A, Bullones Ramírez, Miguel A, Prieto Palomino, Dolores M, Arias García, José L, Castillo Castro
Publikováno v:
Revista espanola de cardiologia. 57(9)
Antagonists of the glycoprotein IIb/IIIa receptor block the binding of fibrinogen and Von Willebrand factor to the platelet receptor. This effect can lead to bleeding and thrombocytopenia. We analyzed the incidence and clinical repercussions of sever
Autor:
Ricardo Rivera-Fernández, Maria Dolores Arias-Verdú, Manuel Delgado-Amaya, Emilio Curiel-Balsera
Publikováno v:
Scandinavian Cardiovascular Journal. 48:255-255